PNDORA Pandora A/S

Long Term Incentive Plans for Executive Management and Other Key Employees in Pandora

Long Term Incentive Plans for Executive Management and Other Key Employees in Pandora

Today, Pandora A/S (“Pandora”) announces the annual allocation of performance shares for 2020 under its Long-term Incentive Plan (“LTIP”), in accordance with its Remuneration Policy.

The LTIP provides a maximum allocation of 100,661 Performance Share Units (“PSUs”) to Pandora’s Executive Management.  In total, considering all participants (Executive Management and key employees) a maximum allocation of 600,000 PSUs is included under the LTIP in 2020.  The maximum allocation of PSUs to all participants under the LTIP in 2020 is only granted if the performance conditions set by the Board are fully achieved.  Based on the allocation share price of DKK 288.10 (the average price of Pandora’s shares on Nasdaq Copenhagen over the last five trading days of 2019), the maximum allocation of PSUs to all participants is valued at DKK 173 million. Pandora intends to use treasury shares to meet its obligations to deliver shares under the LTIP.

The allocated PSUs will be granted following the publication of Pandora's annual report for 2022, subject to fulfilment of the performance conditions in the range 0 – 100% of the maximum PSUs allocated.

For Executive Management the performance conditions are set out in the table below:

LTIP 2020 for

Executive Management:
Weight Vesting % for Achievement of Target
Below

Threshold
At

Threshold
At

Par
At Maximum
Performance Conditions EPS1 50% 0% 0% 50% 100%
TSR2 50% 0% 25% 50% 100%
Total 100% 0% 12.5% 50% 100%
Shares Awarded 0 12,583 50,331 100,661
Value at the allocation share price 0 DKK 3.6m DKK 14.5m DKK 29.0m
  1. Pandora’s Earnings Per Share (EPS) for Financial Year 2022 will be assessed against objectives based on Pandora’s internal financial projections.
  2. Pandora’s relative Total Shareholder Return (TSR) will be ranked (over the period from December 2019 – December 2022) against a basket of 15 industry peer companies.  The threshold for the vesting of 25% of the PSUs linked to the TSR objective is a TSR ranking at median; the maximum for the vesting of 100% of the PSUs is a TSR ranking at top quartile, and pro-rata in between.

5 YEARS’ PROGRAMME FOR EXECUTIVE MANAGEMENT

As the grant of PSUs takes place after the end of the performance period, the PSUs allocated have a vesting period of three years.  For Executive Management, after vesting the PSUs are subject to a further 24 months' holding period after which they become exercisable.  Upon exercise, one PSU entitles the eligible recipient to receive one share in Pandora free of charge.  There are no further performance criteria tied to the 2-year holding period.  In addition, Executive Management meet and continue to be subject to a share ownership requirement of one years’ annual base salary.

In accordance with the relevant International Financial Reporting Standards (IFRSs) the accounting expense for the LTIP will be recognised in the income statement over the 3-year vesting period.

ABOUT PANDORA

Pandora designs, manufactures and markets hand-finished jewellery made from high-quality materials at affordable prices. Pandora jewellery is sold in more than 100 countries through 7,400 points of sale, including more than 2,700 concept stores.

Headquartered in Copenhagen, Denmark, Pandora employs 28,000 people worldwide and crafts its jewellery at two LEED certified facilities in Thailand using mainly recycled silver and gold. The company plans to be carbon neutral by 2025 and has joined the Science Based Targets initiative to reduce emissions across its full value chain. Pandora is listed on the Nasdaq Copenhagen stock exchange and generated sales of DKK 21.9 billion (EUR 2.9 billion) in 2019.

CONTACT

For more information, please contact:

INVESTOR RELATIONS

Michael Bjergby

VP, Investor Relations, Tax & Treasury



CORPORATE COMMUNICATIONS

Johan Melchior

Director External Relations



  
Christian Møller

Investor Relations Officer



 

Attachment

EN
14/07/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Pandora A/S

Pandora AS: 1 director

A director at Pandora AS sold 5,000 shares at 1,138.250DKK and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

ABGSC Consumer Goods Research ... (+3)
  • ABGSC Consumer Goods Research
  • Benjamin Wahlstedt
  • Fredrik Ivarsson
Jesper Ingildsen
  • Jesper Ingildsen

Pandora (Buy, TP: DKK1400.00) - More than charming growth

Top-line growth was once again much stronger than expected, with Q1 LFL growth accelerating to c11%, and trading comments suggest still-solid momentum in April. While comparables are becoming tougher, we believe the brand momentum supported by incremental growth opportunities could prove the revised guidance conservative again. We reiterate our BUY and DKK1,400 target price.

ABGSC Consumer Goods Research ... (+3)
  • ABGSC Consumer Goods Research
  • Benjamin Wahlstedt
  • Fredrik Ivarsson
Jesper Ingildsen
  • Jesper Ingildsen

Pandora (Buy, TP: DKK1400.00) - Likely strong start to the year

Driven by strong brand momentum, increased investments and phased network expansion, we expect Pandora to have seen a strong start to the year (Q1 results due at 07:30 CET on 2 May). We forecast c15% organic growth YOY for Q1 (consensus c12%) and, as flagged by the company, a subdued EBIT margin due to investments. We continue to regard the full-year guidance as conservative (as has tended to be the case) and believe it could be updated with the results. We reiterate our BUY and DKK1,400 target ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch